이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Biocorp Production 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Eric Dessertenne

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.8yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	8.4yrs

최근 관리 업데이트

Recent updates

Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

Dec 08

What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Jun 26

Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

Apr 11

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Mar 04

Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

Jan 10

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

Nov 18

CEO

Eric Dessertenne

3.8yrs

테뉴어

Mr. Eric Dessertenne has been Chief Executive Officer at Biocorp Production since December 23, 2019 and its Director since September 24, 2021. He had been Chief Operating Officer of Biocorp Production sinc...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Eric Dessertenne	CEO & Director	2.1yrs	데이터 없음	데이터 없음
Jean-Yves Berthon	Independent Director	8.4yrs	데이터 없음	데이터 없음
Lutz Heinemann	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Stephane Legastelois	Independent Director	8.4yrs	데이터 없음	데이터 없음
Julien Gardette	Director	8.4yrs	데이터 없음	데이터 없음
Jean-Pierre Riveline	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Pauline Schaepelynck-Belicar	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Novo Nordisk	Chairman of the Board	no data	데이터 없음	데이터 없음

8.4yrs

평균 재임 기간

경험이 풍부한 이사회: ALCOR 의 이사회는 경험(평균 재직 기간 8.4 년)으로 간주됩니다.

Biocorp Production 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Less than half of directors are independent

Recent updates

First half 2023 earnings released: €0.86 loss per share (vs €0.53 loss in 1H 2022)

Novo Nordisk A/S (CPSE:NOVO B) agreed to acquire a 64.4% stake in Biocorp Production (ENXTPA:ALCOR) for €99.1 million.

Novo Nordisk Enters into Exclusive Negotiations to Acquire A Controlling Stake in Bicorp, to Be Followed by A Tender Offer on All Remaining Shares

Full year 2022 earnings released

Biocorp Production to Report First Half, 2023 Results on Sep 28, 2023

Biocorp Production announced that it has received €2.5 million in funding from Vatel Capital SAS

Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?

Biocorp Production Obtains 510(K) FDA Clearance for Mallya

Less than half of directors are independent

First half 2022 earnings released: EPS: €0 (vs €0.28 loss in 1H 2021)

Consensus EPS estimates increase by 38%

What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates

Consensus forecasts updated

Price target increased to €36.53

Less than half of directors are independent

Full year 2021 earnings: Revenues miss analyst expectations

First half 2021 earnings released

Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2020 earnings released

New 90-day high: €30.60

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

BIOCORP Announces the Signature of New Partnerships with Health2sync and SocialDiabetes

New 90-day high: €30.40

Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?

Biocorp Production to Report Fiscal Year 2020 Results on Apr 08, 2021

What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?

BIOCORP Announces Launch of Mallya

New 90-day high: €33.00

Biocorp Production Announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence

New 90-day high - €28.50

CEO

테뉴어

이사회 구성원

평균 재임 기간